Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Cencora, Inc. Common Stock (NY: COR )

242.63 -1.35 (-0.55%)
Official Closing Price Updated: 7:00 PM EST, Feb 14, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 1,277,897
Open 244.00
Bid (Size) 239.49 (1)
Ask (Size) 247.75 (4)
Prev. Close 243.98
Today's Range 242.59 - 246.32
52wk Range 214.77 - 262.25
Shares Outstanding 44,197,721
Dividend Yield 0.84%
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
$100 Invested In Cencora 5 Years Ago Would Be Worth This Much Today
Via Benzinga
The Ultimate Guide To Stock Investing Success
A discussion about how you can really identify stocks that you can add to your portfolio that will be winners in the long run. 
Via Talk Markets
Topics Stocks / Equities

Performance

YTD
+7.96%
+7.96%
1 Month
+0.72%
+0.72%
3 Month
-0.10%
-0.10%
6 Month
+1.58%
+1.58%
1 Year
+4.71%
+4.71%

More News

Read More
10 Health Care Stocks With Whale Alerts In Today's Session
Via Benzinga
Humana Earnings On Deck: Investors Brace For Slower Growth Clip
Via Benzinga
Humana (HUM) Q4 Earnings: What To Expect
Via StockStory
Earnings Scheduled For February 5, 2025
Via Benzinga
$100 Invested In Cencora 10 Years Ago Would Be Worth This Much Today
Via Benzinga
Breaking Down Cencora: 6 Analysts Share Their Views
Via Benzinga
Looking Into Cencora's Recent Short Interest
Via Benzinga
Let's take a look at the S&P500 stocks that are experiencing unusual volume in today's session.
Via Chartmill
Walgreens Cashes In: Slashes Cencora Stake Again In Debt-Fighting Move
Via Benzinga
Cencora Announces Common Share Repurchase From Walgreens Boots Alliance
From Cencora
Via Business Wire
Cencora Q1 Earnings: Revenue And EPS Beat On Strong Push From Obesity Drugs, Specialty Medicines
Via Benzinga
Cencora (NYSE:COR) Reports Upbeat Q4
Via StockStory
Here's How Much You Would Have Made Owning Cencora Stock In The Last 10 Years
Via Benzinga
If You Invested $1000 In This Stock 10 Years Ago, You Would Have This Much Today
Via Benzinga
Stocks Rebound, Google Eyes Worst Drop In A Year, Gold Shatters Fresh Records: What's Driving Markets Wednesday?
Via Benzinga
(COR) - Analyzing Cencora's Short Interest
Via Benzinga
$100 Invested In Cencora 5 Years Ago Would Be Worth This Much Today
Via Benzinga
Cencora Reports Fiscal 2025 First Quarter Results
From Cencora
Via Business Wire
Jim Cramer: Lemonade Is 'Up Too Much,' This Health Care Stock Can Go Lower
Via Benzinga
Cencora Announces Date and Time for First Quarter Fiscal 2025 Earnings Release
From Cencora
Via Business Wire
Cencora Completes Acquisition of Retina Consultants of America
From Cencora
Via Business Wire
Cencora Closes $1.8 Billion Senior Notes Offering
From Cencora
Via Business Wire
Cencora Prices $500 Million 4.625% Senior Notes Due 2027, $600 Million 4.850% Senior Notes Due 2029 and $700 Million 5.150% Senior Notes Due 2035
From Cencora
Via Business Wire
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.